Publication | Open Access
Overexpression of PrP<sup>c</sup> triggers caspase 3 activation: potentiation by proteasome inhibitors and blockade by anti‐PrP antibodies
72
Citations
34
References
2002
Year
Anti‐prp AntibodiesProteasome InhibitorsApoptosisImmunologyProteasomeMolecular BiologyCell DeathCell Death MechanismsSignaling PathwayProteomicsProtein DegradationCell SignalingProtein FunctionCellular Prion ProteinPrpc InternalizationCell BiologyProtein PhosphorylationSignal TransductionNatural SciencesCellular BiochemistryMedicinePrpc Expression
We examined the influence of cellular prion protein (PrPc) in the control of cell death in stably transfected HEK293 cell line and in the PrPc-inducible Rov9 cells. PrPc expression in stably transfected HEK293 human cells did not modify basal apoptotic tonus but drastically potentiated staurosporine-stimulated cellular toxicity and DNA fragmentation as well as caspase 3-like activity and immunoreactivity. An identical staurosporine-induced caspase 3 activation was observed after doxycycline in the PrPc-inducible Rov9 cell line. Interestingly, proteasome inhibitors increase PrPc-like immunoreactivity and unmasked a basal caspase 3 activation. Conversely, we show that anti-PrPc antibodies sequestrate PrPc at the cell surface and drastically lower PrPc-dependent caspase activation. We suggest that intracellular PrPc could sensitize human cells to pro-apoptotic phenotype and that blockade of PrPc internalization could be a track to prevent intracellular toxicity associated with PrPc overexpression.
| Year | Citations | |
|---|---|---|
Page 1
Page 1